Patent · US Expired

Composition for improving pancreatic function

US6232288A · kind A · utility

6Cited by
0References
26Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 15, 1998
Grant dateMay 15, 2001
Priority date
Expiry dateApr 15, 2018

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/22
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a novel composition comprising a betacellulin protein, or a fragment thereof, which is capable of promoting the differentiation of undifferentiated pancreatic cells into insulin-producing beta cells or pancreatic polypeptide producing F cells. This composition can also improve glucose tolerance in patients and inhibit the growth of undifferentiated pancreatic cells. The composition may further comprise activin and/or other molecules. Methods for treating mammals, including humans, are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.